Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

Q: While the story does describe the cost of stenting, it does not provide the cost of the medication for comparison. The story does give the rate of heart attack or death as 19% within 7 years for both the stent and the medication group. Although the study mentions the risk of clotting with drug-coated stents, this is not adequate information on harms. Furthermore, the study does not mention any possible harms of medication. The story adequately describes the design of the current study. The story does not exaggerate the seriousness or prevalence of heart disease. Furthermore, the story clearly states that this study was done on patients at low risk, that is, those with stable heart disease. The story only quotes one cardiologist not associated with the study and gives no rationale for why he was chosen. (Is it because he's in New York and readily available?) The story could have quoted other clinicians or experts who could have provided some valuable perspective on the impact of this new development on the management of heart disease. The story does mention medication as the alternative to stenting. The story clearly states that stenting is very common in the U.S. The story clearly states that stenting is not a new idea. Because the story quotes the lead author of the study and one physician who is not related to the study, the reader can assume the story did not rely on a press release as the sole source of information.

A: Heart study: Most angioplasties not needed
****
Q: The governors of Connecticut, Maryland, New York and Pennsylvania each issued orders or recommendations that residents wear face masks as they emerge from isolation in the coming weeks. “If you are going to be in public and you cannot maintain social distancing, then have a mask, and put that mask on,” said New York Governor Andrew Cuomo, a Democrat. Similar orders were imposed in New Jersey and Los Angeles last week and face coverings were recommended by Kansas Governor Laura Kelly on Tuesday. California Governor Gavin Newsom has said residents across the nation’s most-populous state would likely be wearing masks in public for some time to come. “We are going to be getting back to normal; it will be a new normal,” Connecticut Governor Ned Lamont said, echoing a phrase used by at least two of his fellow governors in recent days. U.S. Midwest governors were also making plans together to restart their economies, said Jordan Abudayyeh, a spokeswoman for Illinois Governor J.B. Pritzker. In Michigan, hundreds of cars flooded the streets around the state Capitol in Lansing on Wednesday to protest Democratic Governor Gretchen Whitmer’s stay-at-home orders, some of the strictest in the country. Some protesters, in the demonstration organized by conservative and pro-President Donald Trump groups, left their cars to gather on the lawn in front of the Capitol building, many of them not wearing masks or practicing social distancing. As of Wednesday night, 30,885 people in the United States had died of COVID-19, the respiratory illness caused by the novel coronavirus, according to a Reuters tally. That includes more than 4,000 deaths newly attributed to the disease in New York City after health officials revised their counting methods to include “probable,” but unconfirmed, cases. Healthcare workers have faced unique health threats while working on the front lines trying to tackle the pandemic. Reuters has identified more than 50 nurses, doctors and medical technicians who have died after being diagnosed with COVID-19 or showing symptoms of it. At least 16 were in New York state. “The emergency room is like a war zone,” said Raj Aya, whose wife, Madhvi Aya - a physician’s assistant in Brooklyn - was one of the healthcare workers who died in New York. As the outbreak begins to slow, political leaders have bickered over how and when to begin the process of unwinding unprecedented lockdowns that have damaged the economy and largely confined Americans to their homes. Washington state Governor Jay Inslee told an afternoon news conference the largest obstacle to a return to normalcy was a shortage of coronavirus tests. “We simply haven’t had enough test kits – they simply do not exist anywhere in the United States right now,” Inslee said, adding the state had purchased about a million swabs, along with vials and test medium but they were just starting to arrive. At his daily White House briefing hours later, Trump boasted that the United States had “the most expansive testing system anywhere in the world”. But, he said, testing was a problem for the states and not the federal government. “We can’t be thinking about a Walmart parking lot,” where some testing is being done, but the states and cities should do that, he said. Senate Democrats on Wednesday unveiled a $30 billion plan to vastly increase nationwide testing for the coronavirus. Trump, citing data suggesting the peak of new infections had passed, said he would announce guidelines on Thursday for reopening the economy. The sweeping closures of businesses have left millions of Americans unemployed and store owners struggling to pay rent. Government data released on Wednesday showed that retail sales dropped by 8.7% in March, the biggest decline since tracking began in 1992. Consumer spending accounts for more than two-thirds of U.S. economic activity. In addition, output at U.S. factories declined by the most since 1946 as the pandemic fractured supply chains. “The economy is almost in free fall,” said Sung Won Sohn, a business economics professor at Loyola Marymount University in Los Angeles. The United States, with the world’s third-largest population, has now suffered the greatest number of reported fatalities from the coronavirus, ahead of Italy and Spain. Globally, the number of infections has crossed the 2 million mark and over 136,000 people have died, a Reuters tally shows. The pathogen emerged last year in China. Trump said on Wednesday his government was trying to determine whether the coronavirus emanated from a lab in Wuhan, China, and Secretary of State Mike Pompeo said Beijing “needs to come clean” on what they know. The official death toll released by the Chinese government stands at about 3,600. The source of the virus remains a mystery. General Mark Milley, chairman of the Joint Chiefs of Staff, said on Tuesday that U.S. intelligence indicated the coronavirus likely occurred naturally, as opposed to being created in a laboratory in China, but there was no certainty either way.

A: Face masks may be 'new normal' in post-virus life as U.S. prepares gradual reopening.
****
Q: The story states that the therapy could cost “thousands of dollars,” so we’ll give it the benefit of the doubt. However, that’s a broad range and we wish the story had told readers whether that means two or three thousand or ten or twenty. We know itâ€™s an early idea and cost projections are somewhat speculative. The story discussed benefits of the vaccine in relative terms only. It quotes a researcher saying “The magnitude of the effects are really impressive,” but never really quantified the magnitude of the effects. The story accurately describes what is known about the harms of the vaccine at this time. The story should have mentioned that more research is needed to determine how safe the vaccine is. The story adequately describes the design of the current study, rightly pointing out that it was small and preliminary and did not demonstrate effectiveness of the vaccine in an important outcome. The story does not appear to engage in disease mongering. The story quotes two experts – the author of the current study and an allergy expert at the National Institute of Allergy and Infectious Diseases. The latter is not exactly an impartial source since NIAID helped fund the study, but he did caution about the signficance of the study, “limited by its small size and the vaccine’s failure to affect the primary immune system response it was designed to look for.” The story does mention alternatives, such as medications, nasal sprays and allergen immunotherapy. The story did state that “a commercial product is still years away.” The story also states that further studies could “eventually lead to drug approval by the FDA.” That’s true, but they could also lead to FDA rejection. It’s almost a meaningless line and could have been deleted without losing anything from the story. The story clearly states that vaccination is a new approach for treating hay fever. There is no way to know if the story relied on a press release as the sole source of information, although much of the information apparently came from the principal investigator at Johns Hopkins and from the National Institute of Allergy and Infectious Diseases, which was one of the funders of the study.

A:
DNA allergy vaccine shows promise
****